Second, we applied siRNA to silence endogenous NNT-AS1 expression in bladder cancer cells in order to investigate the biological effects of NNT-AS1 on the aggressive characteristics of these cells in vitro and in vivo. The gene discussed is NNT; the disease is urinary bladder carcinoma.